Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apellis Pharmaceuticals (APLS) Exchange Rate Effect: 2020-2025

Historic Exchange Rate Effect for Apellis Pharmaceuticals (APLS) over the last 6 years, with Sep 2025 value amounting to $22,000.

  • Apellis Pharmaceuticals' Exchange Rate Effect fell 87.28% to $22,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $101,000, marking a year-over-year decrease of 88.65%. This contributed to the annual value of -$659,000 for FY2024, which is 588.15% down from last year.
  • Latest data reveals that Apellis Pharmaceuticals reported Exchange Rate Effect of $22,000 as of Q3 2025, which was down 96.79% from $685,000 recorded in Q2 2025.
  • Apellis Pharmaceuticals' Exchange Rate Effect's 5-year high stood at $685,000 during Q2 2025, with a 5-year trough of -$1.6 million in Q1 2021.
  • Moreover, its 3-year median value for Exchange Rate Effect was $56,000 (2023), whereas its average is $49,273.
  • In the last 5 years, Apellis Pharmaceuticals' Exchange Rate Effect tumbled by 959.87% in 2021 and then surged by 2,237.50% in 2022.
  • Over the past 5 years, Apellis Pharmaceuticals' Exchange Rate Effect (Quarterly) stood at $8,000 in 2021, then soared by 2,237.50% to $187,000 in 2022, then spiked by 212.30% to $584,000 in 2023, then slumped by 265.24% to -$965,000 in 2024, then plummeted by 87.28% to $22,000 in 2025.
  • Its Exchange Rate Effect was $22,000 in Q3 2025, compared to $685,000 in Q2 2025 and $359,000 in Q1 2025.